Drug intelligence / Profile preview

Neomycin sulphate + Bacitracin zinc

Development stage
Unknown
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical, Ophthalmic
01

Overview

Based on the search results, I'll provide comprehensive information about neomycin sulphate + bacitracin zinc. Neomycin sulphate + bacitracin zinc is a combination antibiotic medication primarily used for topical application. This combination is often formulated with polymyxin B as a triple antibiotic preparation for treating or preventing superficial bacterial infections. ## Composition and Formulation The medication typically contains: - Neomycin sulphate (also spelled sulfate): An aminoglycoside antibiotic - Bacitracin zinc: A polypeptide antibiotic These active ingredients are usually formulated in an ointment base, commonly white petrolatum or mineral oil for topical application[1][2]. ## Mechanism of Action This combination provides a wide spectrum of antibacterial activity through complementary mechanisms: - **Neomycin sulphate**: Bactericidal for many gram-positive and gram-negative organisms. It inhibits protein synthesis by binding with ribosomal RNA and causing misreading of the bacterial genetic code[4]. - **Bacitracin zinc**: Bactericidal for various gram-positive and gram-negative organisms. It interferes with bacterial cell wall synthesis by inhibiting the regeneration of phospholipid receptors involved in peptidoglycan synthesis[4]. ## Clinical Uses The combination is indicated for: 1. Prevention of superficial bacterial skin infections associated with minor cuts, scrapes, or burns[5][9]. 2. Treatment of minor skin infections caused by susceptible bacteria[3][5]. 3. When formulated with polymyxin B, it's used for topical treatment of superficial infections of the external eye and its adnexa[4][8]. ## Microbial Coverage The combination is effective against numerous bacteria including: - Staphylococcus aureus - Streptococci (including Streptococcus pneumoniae) - Escherichia coli - Haemophilus influenzae - Klebsiella-Enterobacter species - Neisseria species - Pseudomonas aeruginosa[4][6] ## Administration The medication is applied topically to the affected area, typically 1-3 times daily or as directed by a healthcare provider[3]. For ophthalmic formulations, specific instructions for eye application must be followed[4][8]. ## Contraindications The medication is contraindicated in: - Individuals with hypersensitivity to any of the components - For ophthalmic formulations: viral diseases of the cornea and conjunctiva, mycobacterial infections, and fungal diseases of ocular structures[6] - Not for injection into the eye or for use in the external ear canal if the eardrum is perforated[5][6] ## Precautions - For external use only - Avoid contact with eyes (for skin formulations) - Prolonged use may lead to overgrowth of non-susceptible organisms - Discontinue use if irritation or hypersensitivity reactions occur[2][5] This combination antibiotic provides effective broad-spectrum coverage for superficial bacterial infections and is available in various formulations for different clinical applications.

Other names
Neomycin sulfate + Bacitracin zinc
02

Targets

C55-PP (Undecaprenyl pyrophosphate)Bacterial Ribosome

Beyond the preview

Go deeper on Neomycin sulphate + Bacitracin zinc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neomycin sulphate + Bacitracin zinc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call